Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To detect resistance gene from serially collected plasma DNA in non-small cell lung cancer
harbouring EGFR activating mutation who are being treated with EGFR TKIs by using castPCR
method.